Nitric oxide-induced regulation of renal organic cation transport after renal ischemia-reperfusion injury

American Journal of Physiology - Renal Physiology

Volumn 301, Issue 5, 2011, Pages

  Schneider, R ^a   Meusel, M ^a   Betz, B ^a   Kersten, M ^a   Moller Ehrlich K ^a   Wanner, C ^a   Koepsell, H ^b   Sauvant, C ^c  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c Department für Orthopädie   (Germany)

Author keywords

AKI; iNOS; L NIL; Nitric oxide; Serotonin

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; N6 (1 IMINOETHYL)LYSINE; NITRIC OXIDE; ORGANIC CATION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 2; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATION TRANSPORT; CONTROLLED STUDY; DOWN REGULATION; DRUG UPTAKE; FEMALE; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CORTEX; KIDNEY ISCHEMIA; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; URINARY EXCRETION; WESTERN BLOTTING;

EID: 80055076947     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00264.2011     Document Type: Article

References (31)

1. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
2. Chatterjee PK, Patel NS, Kvale EO, Cuzzocrea S, Brown PA, Stewart KN, Mota-Filipe H, Thiemermann C. Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury. Kidney Int 61: 862-871, 2002.
3. Goligorsky MS, Brodsky SV, Noiri E. Nitric oxide in acute renal failure: NOS versus NOS. Kidney Int 61: 855-861, 2002.
4. Guan Z, Gobe G, Willgoss D, Endre ZH. Renal endothelial dysfunction and impaired autoregulation after ischemia-reperfusion injury result from excess nitric oxide. Am J Physiol Renal Physiol 291: F619-F628, 2006.
5. Heemskerk S, van Koppen A, van den Broek L, Poelen GJ, Wouterse AC, Dijkman HB, Russel FG, Masereeuw R. Nitric oxide differentially regulates renal ATP-binding cassette transporters during endotoxemia. Pflügers Arch 454: 321-334, 2007.
6. Heemskerk S, Wouterse AC, Russel FG, Masereeuw R. Nitric oxide down-regulates the expression of organic cation transporters (OCT) 1 and 2 in rat kidney during endotoxemia. Eur J Pharmacol 584: 390-397, 2008.
7. Holloway JC, Phifer T, Henderson R, Welbourne TC. Renal acid-base metabolism after ischemia. Kidney Int 29: 989-994, 1986.
8. Huls M, van den Heuvel JJ, Dijkman HB, Russel FG, Masereeuw R. ABC transporter expression profiling after ischemic reperfusion injury in mouse kidney. Kidney Int 69: 2186-2193, 2006.
9. Jagroop IA, Mikhailidis DP. Doxazosin, an alpha1-adrenoceptor antagonist, inhibits serotonin-induced shape change in human platelets. J Hum Hypertens 15: 203-207, 2001.
10. Jonker JW, Wagenaar E, Van Eijl S, Schinkel AH. Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations. Mol Cell Biol 23: 7902-7908, 2003.
11. Karbach U, Kricke J, Meyer-Wentrup F, Gorboulev V, Volk C, Loffing-Cueni D, Kaissling B, Bachmann S, Koepsell H. Localization of organic cation transporters OCT1 and OCT2 in rat kidney. Am J Physiol Renal Physiol 279: F679-F687, 2000.
12. Koepsell H, Endou H. The SLC22 drug transporter family. Pflügers Arch 447: 666-676, 2004.
13. Koepsell H, Lips K, Volk C. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 24: 1227-1251, 2007.
14. Leichtweiss HP, Lubbers DW, Weiss C, Baumgartl H, Reschke W. The oxygen supply of the rat kidney: measurements of intrarenal PO2. Pflügers Arch 309: 328-349, 1969.
15. Lips KS, Luhrmann A, Tschernig T, Stoeger T, Alessandrini F, Grau V, Haberberger RV, Koepsell H, Pabst R, Kummer W. Down-regulation of the non-neuronal acetylcholine synthesis and release machinery in acute allergic airway inflammation of rat and mouse. Life Sci 80: 2263-2269, 2007.
16. Masereeuw R, Moons MM, Russel FG. Rhodamine 123 accumulates extensively in the isolated perfused rat kidney and is secreted by the organic cation system. Eur J Pharmacol 321: 315-323, 1997.
17. Matsuzaki T, Watanabe H, Yoshitome K, Morisaki T, Hamada A, Nonoguchi H, Kohda Y, Tomita K, Inui K, Saito H. Downregulation of organic anion transporters in rat kidney under ischemia/reperfusion-induced acute renal failure. Kidney Int 71: 539-547, 2007.
18. Mehrens T, Lelleck S, Cetinkaya I, Knollmann M, Hohage H, Gorboulev V, Boknik P, Koepsell H, Schlatter E. The affinity of the organic cation transporter rOCT1 is increased by protein kinase C-dependent phosphorylation. J Am Soc Nephrol 11: 1216-1224, 2000.
19. Minuesa G, Volk C, Molina-Arcas M, Gorboulev V, Erkizia I, Arndt P, Clotet B, Pastor-Anglada M, Koepsell H, Martinez-Picado J. Transport of lamivudine [(-)-beta-L-2=,3=-dideoxy-3=-thiacytidine] and highaffinity interaction of nucleoside reverse transcriptase inhibitors with human organic cation transporters 1, 2, and 3. J Pharmacol Exp Ther 329: 252-261, 2009.
20. Nelimarkka O, Niinikoski J. Oxygen and carbon dioxide tensions in the canine kidney during arterial occlusion and hemorrhagic hypotension. Surg Gynecol Obstet 158: 27-32, 1984.
21. Nies AT, Koepsell H, Damme K, Schwab M. Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy. Handb Exp Pharmacol 201: 105-167, 2011.
22. Notenboom S, Miller DS, Kuik LH, Smits P, Russel FG, Masereeuw R. Short-term exposure of renal proximal tubules to gentamicin increases long-term multidrug resistance protein 2 (Abcc2) transport function and reduces nephrotoxicant sensitivity. J Pharmacol Exp Ther 315: 912-920, 2005.
23. Sauvant C, Schneider R, Holzinger H, Renker S, Wanner C, Gekle M. Implementation of an in vitro model system for investigation of reperfusion damage after renal ischemia. Cell Physiol Biochem 24: 567-576, 2009.
24. Sauvant C, Schneider R, Holzinger H, Renker S, Wanner C, Gekle M. Indomethacin corrects alterations associated with ischemia/reperfusion in an in vitro proximal tubular model. Am J Nephrol 32: 57-65, 2010.
25. Schlatter E, Monnich V, Cetinkaya I, Mehrens T, Ciarimboli G, Hirsch JR, Popp C, Koepsell H. The organic cation transporters rOCT1 and hOCT2 are inhibited by cGMP. J Membr Biol 189: 237-244, 2002.
26. Schneider R, Meusel M, Renker S, Bauer C, Holzinger H, Roeder M, Wanner C, Gekle M, Sauvant C. Low-dose indomethacin after ischemic acute kidney injury prevents down regulation of Oat1/3 and improves renal outcome. Am J Physiol Renal Physiol 297: F1614-F1621, 2009.
27. Schneider R, Sauvant C, Betz B, Otremba M, Fischer D, Holzinger H, Wanner C, Galle J, Gekle M. Downregulation of organic anion transporters OAT1 and OAT3 correlates with impaired secretion of paraaminohippurate after ischemic acute renal failure in rats. Am J Physiol Renal Physiol 292: F1599-F1605, 2007.
28. Slitt AL, Cherrington NJ, Hartley DP, Leazer TM, Klaassen CD. Tissue distribution and renal developmental changes in rat organic cation transporter mRNA levels. Drug Metab Dispos 30: 212-219, 2002.
29. Sun H, Frassetto L, Benet LZ. Effects of renal failure on drug transport and metabolism. Pharmacol Ther 109: 1-11, 2006.
30. Thomas MC, Jerums G, Tsalamandris C, MacIsaac R, Panagiotopoulos S, Cooper ME. Increased tubular organic ion clearance following chronic ACE inhibition in patients with type 1 diabetes. Kidney Int 67: 2494-2499, 2005.
31. Wright SH. Role of organic cation transporters in the renal handling of therapeutic agents and xenobiotics. Toxicol Appl Pharmacol 204: 309-319, 2005